Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MTOR | P42345 | 6/20 | 0.61 |
| ▸ | RPTOR | Q8N122 | 6/20 | 0.61 |
| ▸ | MLST8 | Q9BVC4 | 6/20 | 0.61 |
| ▸ | RET | P07949 | 8/20 | 0.42 |
| ▸ | PPARG | P37231 | 1/20 | 0.42 |
| ▸ | DRD2 | P14416 | 1/20 | 0.40 |
| ▸ | DRD3 | P35462 | 1/20 | 0.40 |
| ▸ | SLC27A1 | Q6PCB7 | 1/20 | 0.40 |
| ▸ | PRKAA2 | P54646 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20159112 | 0.89 | MTOR (0.58) | MTORRPTORMLST8PPARGSLC27A1 | |
| SCHEMBL20158990 | 0.88 | MTOR (0.77) | MTORRPTORMLST8 | |
| SCHEMBL20159082 | 0.88 | MTOR (0.75) | MTORRPTORMLST8DRD2DRD3 | |
| SCHEMBL20158988 | 0.87 | MTOR (0.73) | MTORRPTORMLST8DRD2DRD3 | |
| SCHEMBL20156964 | 0.85 | MTOR (0.49) | MTORRPTORMLST8RETPPARG | |
| SCHEMBL20159152 | 0.85 | MTOR (0.65) | MTORRPTORMLST8DRD2DRD3 | |
| SCHEMBL20159217 | 0.85 | MTOR (0.74) | MTORRPTORMLST8DRD2DRD3 | |
| SCHEMBL20140388 | 0.85 | MTOR (0.47) | MTORRPTORMLST8RETPPARG | |
| SCHEMBL20159156 | 0.84 | MTOR (0.64) | MTORRPTORMLST8DRD2DRD3 | |
| SCHEMBL20139894 | 0.84 | MTOR (0.47) | MTORRPTORMLST8RETSLC27A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2018089493-A1 | PYRROLE mTORC INHIBITORS AND USES THEREOF | NAVITOR PHARMACEUTICALS, INC. (US) | 2018-05-17 | — | — | WO | disclosed |